Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-09-26

Clinical Trial Update: Lifestyle Versus Ezetimibe Plus Lifestyle in Patients With Non-alcoholic Steatohepatitis [Phase 4]

View source ↗

Summary

Phase 4 trial comparing lifestyle modification alone versus lifestyle modification plus ezetimibe in patients with non-alcoholic steatohepatitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EZETIMIBE (EZETIMIBE)

Snippet

Sponsor: University of Palermo | Conditions: •Non-alcoholic Steatohepatitis (NASH) | Phase 4 | Status: UNKNOWN